I Can See Health

The experiment of the National Natural Science Project officially came to an end.

Lu Chen's research team also had a break.

But everyone was on edge.

No one dares to relax until the final result comes out.

Generally speaking, the review time of the editorial department of "" is about three months.

However, under the influence of AstraZeneca's headquarters, the "News" editorial department reviewed two clinical research papers as soon as possible.

This time, the peer reviewers invited by the editorial department of "" are also top experts in the cardiovascular field.

Among them, Professor Fan Boyan of Harvard Medical School in the United States stands out.

Professor Fan Boyan is a reviewer for many top journals. In the field of cardiovascular disease, he can be said to be the number one person in China!

…

Harvard Medical School, Harvard University, United States.

Professor Fan Boyan looked surprised. Looking at the paper in front of him, he couldn't help but think of the paper from China some time ago.

"AstraZeneca is such a generous person!" Professor Fan Boyan exclaimed, "Two branches conduct scientific research experiments. How much manpower, material resources and other resources will be consumed!"

However, for a giant company like AstraZeneca, a lot of money has been invested, and the results produced are extremely amazing.

No matter which branch's research results are published this time, it will be a sure win for AstraZeneca.

Further breakthroughs have been made in research, and the value that dapagliflozin can create far exceeds the current investment.

Soon, Professor Fan Boyan read AstraZeneca’s two papers. .

Comparing the two papers together, he had a more intuitive feeling.

Having experienced the last review, Professor Fan Boyan easily found this paper from China.

The same experimental procedures and the same statistical methods.

"When did China create such a powerful research team?"

Professor Fan Boyan showed a happy smile on his face.

Any research experiment must be based on changing the guidelines for clinical treatment, and at least be clinically helpful.

Huaxia's daily output of papers is not low, and is even among the highest in the world.

However, there are very few experiments that are truly meaningful and can be translated into clinical results!

“Jinghua’s paper on dapagliflozin is definitely a treatment guideline that can change clinical practice!”

…

Kyoto University School of Medicine, First Affiliated Hospital.

District 3, Director's Office.

Wan Jingshui and Fang Ruzhang sit opposite each other.

When they learned that Lu Chen was cooperating with AstraZeneca's Chinese branch, both of them were silent for a while.

Who knew Lu Chen could be on this list?

"Director, if I had known better, we wouldn't have quit..."

Fang Ruzhang regretted it.

What a great opportunity this is!

Now the entire academic circle in the cardiovascular field is focused on this battle between AstraZeneca China and Europe!

If you can win, it will definitely be an opportunity to gain reputation in the international academic circle.

What's more, if it can change clinical guidelines, it can leave its name in the entire history of medical development.

"Jinghua just took this ride." Wan Jingshui snorted coldly, "With their current capabilities, can they meet the standards of ""? Taking a step back, they can beat AstraZeneca Europe Branch?"

Fang Ruzhang felt a burst of slander in his heart.

Anyway, this is ""!

A journal that even Director Wan Jingshui himself cannot match...

…

Another place in Kyoto.

China National Fund Committee Office.

The second round of offline defense sessions for "Outstanding Youth" will begin next week.

Li Yao has come to Kyoto in advance to smoothen connections for his path to "outstanding youth".

As Li Yao's recommender, Ouyang Ming also followed her to visit various bosses.

Li Yao originally thought that she still had some hope and could catch the last train of "outstanding youth".

But after these few days of communication, she also recognized a reality.

She herself is still far away from the title of "Outstanding Youth" academically!

What's more important is that most of the "outstanding youth" quotas are actually reserved.

Gu'an

Only a very small portion of the quotas are still subject to change.

This is also the inside story she gradually learned after coming to Kyoto.

"Xiaoyao, don't be discouraged." Ouyang Ming said comfortingly, "There are more places this year than before. I made a rough estimate and there are at least five places left."

Li Yao smiled reluctantly, "I will try my best."

Although there are still five spots available, there are hundreds of people participating in the election at the same time!

Scholars who can pass the first round of preliminary review have strong connections behind them.

What is competing now is the past scientific research results of all scholars.

There are not many papers that Li Yao can produce.

In addition to a 14-point sci paper that he had completed as the first author, the only remaining one was the 11.98-point sci paper that Lu Chen published some time ago.

Li Yao has studied his competitors.

As applicants in the medical field, many others have several high-quality papers, some of which have scores of 15 or more, and even more, reaching 18 scores!

Li Yao knew very well that she had no advantages in terms of education background or current scientific research background.

…

Time passes day by day.

For everyone in Lu Chen's research team, every day is a bit of a struggle.

They are constantly refreshing the latest academic information and want to know the latest developments at AstraZeneca headquarters as soon as possible.

After the initial nervous wait, Lu Chen became calm now.

The ending cannot be changed, so just face it calmly.

During this time, he was not idle either.

Instead, he came to the Catheterization Laboratory of the Cardiology Department of Jinghua Second Hospital.

Director Cheng Guowen should be the happiest about his arrival.

Lu Chen's current electrophysiology level is unmatched by anyone in Jinghua Second Hospital.

For some relatively difficult electrophysiological surgeries, Lu Chen would take the initiative to act as the chief surgeon.

The addition of Lu Chen also greatly improved the surgical capabilities of the interventional cardiology doctors at Jinghua Second Hospital.

In the catheterization room of Jinghua Second Hospital at this time.

Lu Chen is instructing some attending doctors to perform dry pericardiocentesis surgery.

"Some arrhythmias originating from the endocardium may involve dry pericardiocentesis. How to correctly puncture the origin is extremely important for patients with arrhythmias..."

Lu Chen explained and gave practical demonstrations to everyone.

Most of the people who come to study are attending doctors, including some deputy chief physicians.

None of them dared to underestimate the young doctor in front of them.

Everyone was attentive and listened attentively to the explanation about the surgery.

The lecture is over.

A group of doctors pulled Lu Chen and asked him various surgical questions.

Lu Chen responded with a smile one by one, accepting everyone who came!

The amount of gratitude given by these senior doctors cannot be compared to the amount of gratitude given by junior sisters.

After finally answering everyone's questions, Lu Chen came to the lounge.

Picking up his phone, he looked stunned.

There are eight missed calls in total!

The key thing is that all these missed calls came from Wang Ruoxi alone!

Have the results of the paper been released?

Lu Chen's heart tightened slightly, UU reading www.uukanshu.net He quickly picked up his phone and called Wang Ruoxi.

beep……

The phone rang once and was answered.

"Hello, Sister Ruoxi?"

"Lu Chen, you finally answered the phone!"

Wang Ruoxi's voice was full of joy, "We won!"

"Sister Ruoxi, what did you say, you won?"

Lu Chen immediately stood up, with an indescribable surprise flashing in his eyes.

Wang Ruoxi seemed to calm down her excitement and repeated, "Our Chinese branch won!"

"Jinghua wins!"

"Lu Chen, you win!"

.